BlackRock reduces long position in Fosun Pharma H-shares to 5.78%
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
On September 25, Southern Finance Network reported, citing a Hong Kong Exchange filing, that BlackRock, Inc. reduced its long position (good warehouse) in Fosun Pharmaceutical's H-shares. The stake decreased from 6.30% to 5.78% on September 22, a drop of 0.52 percentage points. The information was disclosed via the Hong Kong Exchange's disclosure system. The report was published by East Money's company news channel, with the original source being Southern Finance Network. No further details or commentary on the reason for the reduction were provided in the brief item.
Source report
September 25 – According to a disclosure filing with the Hong Kong Stock Exchange, BlackRock, Inc. has reduced its long position (L) in Fosun Pharma's H-shares.
The stake decreased from 6.30% to 5.78% on September 22.
Source: Southern Finance Network
Source
东方财富网-公司报道Eastern
Part of this Story
BlackRock Adjusts H-Share Stakes in COSCO Shipping and Sinopec in September 2024